US FDA to step up inspections of drug manufacturing facilities in India
The US drug regulator is set to increase inspections at Indian drug manufacturing facilities in 2024 amid growing concerns over drug quality, a top Food and Drug Administration official told Reuters.
POPULAR POSTS
Trump opts for personal ties to choose his government team
November 15, 2024
UK sets new climate target for 2035
November 13, 2024
Children go back to school after Valencia floods
November 13, 2024
Researchers document huge decline in African elephants
November 13, 2024
LIVE STREAM
